The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Placebo-Controlled, Randomized Clinical Trial of Azimilide for Prevention of Ventricular Tachyarrhythmias in Patients With an Implantable Cardioverter Defibrillator
Open accessAbstract
Background— Although implanted cardioverter defibrillators (ICDs) effectively treat sustained ventricular tachyarrhythmias, up to 50% of ICD recipients eventually require concomitant antiarrhythmic drug therapy to prevent symptomatic arrhythmia recurrences and hence reduce the number of device therapies. Methods and Results— A total of 633 ICD recipients were enrolled in a randomized, double-blind, placebo-controlled study to evaluate the effect of daily doses of 75 or 125 mg of azimilide on recurrent symptomatic ventricular tachyarrhythmias and ICD therapies. Total all-cause shocks plus symptomatic ventricular tachycardia (VT) terminated by antitachycardia pacing (ATP) were significantly reduced by azimilide, with relative risk reductions of 57% (hazard ratio [HR]=0.43, 95% CI 0.26 to 0.69, P =0.0006) and 47% (HR=0.53, 95% CI 0.34 to 0.83, P =0.0053) at 75- and 125-mg doses, respectively. The reductions in all-cause shocks with both doses of azimilide did not achieve statistical significance. The incidence of all appropriate ICD therapies (shocks or ATP-terminated VT) was reduced significantly among patients taking 75 mg of azimilide (HR=0.52, 95% CI 0.30 to 0.89, P =0.017) and those taking 125 mg of azimilide (HR=0.38, 95% CI 0.22 to 0.65, P =0.0004). Five patients in the azimilide groups and 1 patient in the placebo group had torsade de pointes; all were successfully treated by the device. One patient taking 75 mg of azimilide had severe but reversible neutropenia. Conclusions— Azimilide significantly reduced the recurrence of VT or ventricular fibrillation terminated by shocks or ATP in ICD patients, thereby reducing the burden of symptomatic ventricular tachyarrhythmia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Azimilide also decreases ICD shocks, 29”
From Managing with pacemakers and implantable cardioverter defibrillators (2013) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Self-citationCox’s regression model for counting processes: A large sample study
Andersen, P. K., & Gill, R. D. (1982) · The Annals of Statistics · doi:10.1214/aos/1176345976 · Cited by 4,419
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,244
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
Connolly, S. J. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2476 · Cited by 1,138
Semiparametric regression for the mean and rate functions of recurrent events
Lin, D. Y., Wei, L. J., Yang, I., & Ying, Z. (2000) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00259 · Cited by 969
Use of the Kolmogorov–Smirnov, Cramér–Von Mises and Related Statistics Without Extensive Tables
Stephens, M. A. (1970) · Journal of the Royal Statistical Society Series B (Statistical Methodology) · doi:10.1111/j.2517-6161.1970.tb00821.x · Cited by 582
CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION
Julian, D. G., Jackson, F. S., Prescott, R. J., & Szekely, P. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92225-5 · Cited by 430
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
Self-citationElectrical Storm Presages Nonsudden Death
Exner, D. V., Pinski, S. L., Wyse, D. G., Renfroe, E. G., Follmann, D. A., Gold, M. R., Beckman, K. J., Coromilas, J., Lancaster, S. E., & Hallstrom, A. P. (2001) · Circulation · doi:10.1161/01.cir.103.16.2066 · Cited by 393
Electrical storm in patients with transvenous implantable cardioverter-defibrillators
Credner, S., Klingenheben, T., Mauß, O., Sticherling, C., & Hohnloser, S. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00495-1 · Cited by 375
Self-citation
Cited by
Sorted by citations
Items 101–155 of 155
Management of Arrhythmias in Heart Failure
ADELSTEIN, E. C., & Ganz, L. I. (2008) · Springer eBooks · doi:10.1007/978-1-84800-102-2_8 · Cited by 3
Hospital readmission in patients with implantable cardioverter-defibrillators.
Kaźmierczak, J., Zielonka, J., Rzeuski, R., Peregud‐Pogorzelska, M., Gorący, J., Biernawska, J., Sulikowski, T., & Kornacewicz‐Jach, Z. (2006) · PubMed · Cited by 3
Update on primary prevention implantable cardioverter-defibrillator therapy
Epstein, A. E. (2009) · Current Cardiology Reports · doi:10.1007/s11886-009-0047-3 · Cited by 3
Ventricular Tachycardia Ablation as First Line Therapy: Are We There Yet?
Biase, L. D., Santangeli, P., Burkhardt, J. D., & Natale, A. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12107 · Cited by 3
Jacobson, J. T., Iwai, S., & Aronow, W. S. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.02.015 · Cited by 3
Ranolazine in Patients With Implantable Cardioverter-Defibrillators
Albert, C. M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.008 · Cited by 3
Clinical Trials of Defibrillator Therapy
Exner, D. V. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1616-0.00011-4 · Cited by 3
Management of ventricular tachycardia in patients with advanced heart failure
Liuba, I., Sroubek, J., & Santangeli, P. (2025) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2025.04.006 · Cited by 2
Inappropriate Implantable Cardioverter-Defibrillator Therapy
Ardhanari, S., Shah, A. J., Gadeela, N., & Thakur, R. K. (2009) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2009.08.002 · Cited by 2
Chevalier, P., Durand‐Dubief, A., Piqueras, E., Pineau, J., Rivard, L., Morel, É., Bui-xan, B., & Timour, Q. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318150d3f5 · Cited by 2
Ramineni, R., Bheemarasetti, M. K., Baranchuk, A. M., Mandalapu, T., Mukku, V. K. R., Fujise, K., & Barbagelata, A. (2012) · Cardiology Journal · doi:10.5603/cj.2012.0107 · Cited by 2
Drug-implantable cardioverter–defibrillator interactions
Beadle, R. M., Williams, L. K., & Lim, H. S. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.114 · Cited by 2
Clinical Pharmacology of Antiarrhythmic Drugs
Woosley, R. L., & Shirazi, F. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3358-5.50025-5 · Cited by 2
Kakarla, J., Benson, C., Abbas, M., Begg, G. A., Twomey, D. J., Thornley, A. R., Bates, M. G. D., Ahmad, M., Arif, H. A., Banerjee, A., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014733 · Cited by 2
Reiffel, J. A. (2007) · Current Cardiology Reports · doi:10.1007/bf02938365 · Cited by 2
Unresolved Issues in Implantable Cardioverter-Defibrillator Therapy
Mason, P. K., & Dimarco, J. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.03.008 · Cited by 2
The Shocking Story of Azimilide
Hanna, I. R., & Langberg, J. J. (2004) · Circulation · doi:10.1161/01.cir.0000151357.36405.72 · Cited by 2
Implantable Cardioverter–Defibrillator Therapy after Myocardial Infarction
Micheletta, F., Natoli, S., & Iuliano, L. (2005) · New England Journal of Medicine · doi:10.1056/nejm200503103521017 · Cited by 2
Clinical Trials of Defibrillator Therapy
Exner, D. V. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-2536-8.50016-9 · Cited by 2
Electrical Storm: Clinical Management
Metaxa, S., Koulouris, S. N., & Manolis, A. S. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5316-0_23 · Cited by 1
Antiarrhythmic Drug Therapy for New-Onset Ventricular Arrhythmia (VT/VF) in ICD Patients
Nair, G. M., Healey, J. S., Divakaramenon, S., Connolly, S. J., & Morillo, C. A. (2011) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2011.08.009 · Cited by 1
Kapa, S., & Hutchinson, M. D. (2012) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2012.02.006 · Cited by 1
Drugs acting on the heart: anti-arrhythmics
Hebbes, C. P., & Thompson, J. P. (2015) · Anaesthesia & intensive care medicine · doi:10.1016/j.mpaic.2015.02.009 · Cited by 1
Glikson, M., Luria, D. M., Gurevitz, O. T., & Friedman, P. A. (2008) · Springer eBooks · doi:10.1007/978-1-84628-854-8_56 · Cited by 1
Ablation of Ventricular Tachycardia in Coronary Artery Disease
Haqqani, H. M., & Callans, D. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-1368-8.00028-3 · Cited by 1
Colella, A., Giaccardi, M., Sabatini, A., Zuppiroli, A., & Franco, G. (2011) · InTech eBooks · doi:10.5772/22503
Time Dependence of Arrhythmias in ICD Patients
Faulknier, B. A., Huang, D. T.-C., & Daubert, J. P. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2008.01178.x · Cited by 1
Cannom, D. S., & Gidney, B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.07.003 · Cited by 1
Self-citationProgrammed Stimulation During Mapping and Ablation of VT
Khaykin, Y. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5316-0_39
Clinical Role of Antiarrhythmic Drugs in the Prevention of Sudden Death
Lee, H.-C., & Huang, K. T. L. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4978-1_33
Prevention and Treatment of Life‐Threatening Ventricular Arrhythmia and Sudden Death
Morillo, C. A., & Baranchuk, A. M. (2009) · doi:10.1002/9781444309768.ch40
Chronic Suppression of Ventricular Tachyarrhythmias in Patients with ICDs
Zawaneh, M. S., & Stambler, B. S. (2010) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2010.06.008
Who needs a transplant and when?
Chan, W. X., & Ross, H. J. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283574185
Brigadeau, F., Kouakam, C., Boulé, S., Marquié, C., & Klug, D. (2010) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(10)70372-4
Reducing ICD Shocks for Ventricular Arrhythmias
Schoenhard, J. A., & Zei, P. C. (2011) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2011.05.013
Acute Antiarrhythmic Therapy of Ventricular Tachycardia and Ventricular Fibrillation
Viswanathan, M. N., & Page, R. L. (2010) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2010.07.001
Electrical Storm and Pharmacological Treatment on Critical Care
Porter, R., & Bryden, D. C. (2011) · Journal of the Intensive Care Society · doi:10.1177/175114371101200417
Link, M. G., & Kowey, P. (2009) · Pacing and clinical electrophysiology : PACE · doi:10.1111/j.1540-8159.2008.02234.x
Antiarrhythmic Drug Management
Hsia, H. H., & Matsuda, K. Y. (2010) · Springer eBooks · doi:10.1007/978-0-387-77452-7_51
Zipes, D. P., Buxton, A. E., Gregoratos, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quiñones, M. A., von Roden, M., & Silka, M. J. (2006)
Self-citationIncreased extracellular volume fraction in heart failure
Eyüboğlu, M. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000314
Proietti, R., Labos, C., Davis, M. R., Thanassoulis, G., Santangeli, P., Russo, V., Roux, J.-F., Verma, A., Natale, A., & Essebag, V. (2015)
Droogan, C. J., Patel, C., Yan, G., & Kowey, P. R. (2011)
Pharmakotherapie der ventrikulären Rhythmusstörungen
Wegener, F., Grönefeld, G., Duray, G. Z., Ehrlich, J. R., & Hohnloser, S. H. (2006) · Der Internist · doi:10.1007/s00108-005-1561-z
Self-citationRoukoz, H., Adkisson, W. O., Akdemir, B., Krishnan, B., Sakaguchi, S., & Benditt, D. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-44577-9_19
OBSOLETE: Management of Ventricular Tachycardia in Ischemic and Nonischemic Cardiomyopathy
Sapp, J. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99776-9
Repetitive ICD Shocks and Incessant VTs in Heart Failure: What to Do?
Eisenberger, M., Potter, T. J. R. D., & Geelen, P. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7345-9_7
Darbar, D., & Roden, D. M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50029-9
Antiarrhythmische Therapiemaßnahmen im Überblick
(2007) · Steinkopff eBooks · doi:10.1007/978-3-7985-1752-3_1
Clinical Role of Antiarrhythmic Drugs in the Prevention of Sudden Death
Lee, H.-C. (2008) · Springer eBooks · doi:10.1007/978-1-84628-854-8_53
Krankheitsbilder und ihre spezifische antiarrhythmische Therapie
(2007) · Steinkopff eBooks · doi:10.1007/978-3-7985-1752-3_2
Paulin, F. L., & Exner, D. V. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1367-1.00081-1
Management of Ventricular Tachycardia in Ischemic and Nonischemic Cardiomyopathy
AbdelWahab, A., Kuriachan, V. P., Sumner, G., Mitchell, L. B., & Sapp, J. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99776-x
Molecular Study of Sudden Cardiac Death
Hostiuc, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126366
AbdelWahab, A. M., Kuriachan, V. P., Mitchell, L. B., & Sapp, J. L. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00040-6
Metadata
- Authors
- Dorian, P., Borggrefe, M., Al-Khalidi, H. R., Hohnloser, S. H., Brum, J. M., Tatla, D. S., Brachmann, J., Myerburg, R. J., Cannom, D. S., van der Laan, M., Holroyde, M. J., Singer, I., & Pratt, C. M.
- Affiliations
- Goethe University Frankfurt (DE)
- From the Division of Cardiology, St. Michael’s Hospital (P.D.), Toronto, Ontario, Canada; Klinikum Mannheim (M.B.), Universtatsklinikum, Mannheim, Germany; Health Care Research Center (H.R.A.-K., J.M.B., D.S.T., M.J.H.), Procter & Gamble Pharmaceuticals, Cincinnati, Ohio; J.W. Goethe University (S.H.H.), Department of Cardiology, Division of Electrophysiology, Frankfurt, Germany; Landkrankenhaus Coburg (J.B.), II Medizinische Klinik, Coburg, Germany; University of Miami School of Medicine (R.J.M...
- Venue
- Circulation
- Published
- 2004-12-14
- Volume
- 110
- Issue
- 24
- Pages
- 3646-3654
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2147134314
- Cited by
- 155
- References
- 29
- Citations by year
- 2025: 3 · 2024: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 6 · 2018: 5 · 2017: 10 · 2016: 6 · 2015: 4 · 2014: 3 · 2013: 14 · 2012: 6
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Keywords
- azimilide, implantable cardioverter-defibrillator, ventricular tachyarrhythmia, antiarrhythmic drugs, arrhythmia recurrence prevention, ICD shocks, antitachycardia pacing, ventricular fibrillation, torsades de pointes, neutropenia, dose comparison
- MeSH terms
- Anti-Arrhythmia Agents, Double-Blind Method, Electric Countershock, Female, Humans, Hydantoins, Male, Middle Aged, Piperazines, Defibrillators, Implantable, Tachycardia, Ventricular, Endpoint Determination, Imidazolidines, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
